Biorestorative Therapies (BRTX) Competitors $1.46 -0.03 (-1.70%) Closing price 03:57 PM EasternExtended Trading$1.50 +0.04 (+2.42%) As of 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BRTX vs. BMGL, MRAI, CCM, BGLC, NIVF, MGRX, SSY, DHAC, VSEE, and ACONShould you be buying Biorestorative Therapies stock or one of its competitors? The main competitors of Biorestorative Therapies include Basel Medical Group (BMGL), Marpai (MRAI), Concord Medical Services (CCM), BioNexus Gene Lab (BGLC), NewGenIvf Group (NIVF), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Digital Health Acquisition (DHAC), VSee Health (VSEE), and Aclarion (ACON). These companies are all part of the "healthcare" industry. Biorestorative Therapies vs. Its Competitors Basel Medical Group Marpai Concord Medical Services BioNexus Gene Lab NewGenIvf Group Mangoceuticals SunLink Health Systems Digital Health Acquisition VSee Health Aclarion Basel Medical Group (NASDAQ:BMGL) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, media sentiment, earnings and valuation. Is BMGL or BRTX more profitable? Basel Medical Group has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,093.61%. Basel Medical Group's return on equity of 0.00% beat Biorestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets Basel Medical GroupN/A N/A N/A Biorestorative Therapies -3,093.61%-129.47%-86.02% Do insiders & institutionals believe in BMGL or BRTX? 69.4% of Biorestorative Therapies shares are owned by institutional investors. 25.5% of Biorestorative Therapies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, BMGL or BRTX? Basel Medical Group has higher earnings, but lower revenue than Biorestorative Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBasel Medical GroupN/AN/AN/AN/AN/ABiorestorative Therapies$400K27.46-$8.98M-$1.47-1.00 Do analysts prefer BMGL or BRTX? Biorestorative Therapies has a consensus target price of $18.00, indicating a potential upside of 1,129.00%. Given Biorestorative Therapies' stronger consensus rating and higher possible upside, analysts plainly believe Biorestorative Therapies is more favorable than Basel Medical Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Basel Medical Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biorestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer BMGL or BRTX? In the previous week, Biorestorative Therapies had 1 more articles in the media than Basel Medical Group. MarketBeat recorded 1 mentions for Biorestorative Therapies and 0 mentions for Basel Medical Group. Basel Medical Group's average media sentiment score of 0.00 equaled Biorestorative Therapies'average media sentiment score. Company Overall Sentiment Basel Medical Group Neutral Biorestorative Therapies Neutral SummaryBiorestorative Therapies beats Basel Medical Group on 7 of the 10 factors compared between the two stocks. Get Biorestorative Therapies News Delivered to You Automatically Sign up to receive the latest news and ratings for BRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BRTX vs. The Competition Export to ExcelMetricBiorestorative TherapiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.18M$3.02B$5.57B$9.48BDividend YieldN/A2.42%4.31%4.13%P/E RatioN/A5.8618.7821.62Price / Sales27.46306.36441.7495.96Price / CashN/A42.1735.8458.51Price / Book1.197.818.085.58Net Income-$8.98M-$54.52M$3.26B$265.35M7 Day Performance-1.04%-0.87%-0.73%-0.89%1 Month Performance-7.54%13.63%5.52%4.98%1 Year Performance6.14%11.57%28.79%23.50% Biorestorative Therapies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BRTXBiorestorative Therapies3.0408 of 5 stars$1.46-1.7%$18.00+1,129.0%+13.7%$11.18M$400K0.007News CoverageUpcoming EarningsBMGLBasel Medical GroupN/A$2.05-0.5%N/AN/A$37.83M$10.00M0.0036MRAIMarpaiN/A$1.34-0.7%N/A+152.8%$22.33M$34.87M-0.51150News CoverageUpcoming EarningsCCMConcord Medical ServicesN/A$5.05-5.4%N/A-25.8%$21.92M$52.60M0.00970Gap UpBGLCBioNexus Gene Lab0.211 of 5 stars$5.73-13.7%N/A+31.1%$10.31M$9.51M0.0030Upcoming EarningsShort Interest ↑Gap DownNIVFNewGenIvf GroupN/A$2.24-5.1%N/A-99.7%$9.68M$5.43M0.00N/AGap DownMGRXMangoceuticals0.9922 of 5 stars$1.77+1.1%N/A-97.8%$9.15M$511.08K-0.383Positive NewsUpcoming EarningsSSYSunLink Health Systems1.1369 of 5 stars$1.02-8.9%N/A+19.3%$7.18M$31.09M7.291,376High Trading VolumeDHACDigital Health AcquisitionN/A$1.39+14.9%N/A-47.9%$5.01MN/A0.002,021High Trading VolumeVSEEVSee Health1.3734 of 5 stars$1.37-1.4%$5.00+265.0%-48.7%$4.93MN/A0.00N/APositive NewsGap DownACONAclarion1.8395 of 5 stars$7.37+5.3%$11,758.50+159,380.5%-99.7%$4.29M$54.60K0.007News CoverageUpcoming EarningsGap Up Related Companies and Tools Related Companies Basel Medical Group Competitors Marpai Competitors Concord Medical Services Competitors BioNexus Gene Lab Competitors NewGenIvf Group Competitors Mangoceuticals Competitors SunLink Health Systems Competitors Digital Health Acquisition Competitors VSee Health Competitors Aclarion Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BRTX) was last updated on 8/6/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredGuess Who the Gvt Could Partner With Next?The Government Just Made a $400M Bet. Who's Next? A $100 trillion wealth shift is quietly underway... and t...Stansberry Research | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[Warning] Buffett Indicator hits new All-Time-HighWarren Buffett has leaned on one key indicator for decades—and it just hit an all-time high. That’s not bullis...Golden Portfolio | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biorestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biorestorative Therapies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.